01 Cold-Chain Infrastructure Expands for Temperature-Sensitive Medicines The pharmaceutical logistics market is changing as more medicines require controlled temperatures during storage and transportation. Vaccines, biologics, specialty medicines, and cell and gene therapies need carefully managed conditions to maintain their quality from manufacturing facilities to patients. Logistics companies are therefore expanding refrigerated warehouses, temperature-controlled vehicles, specialized packaging, and monitoring systems. This is supporting pharmaceutical logistics market growth as pharmaceutical supply chains become more specialized. For instance, in February 2026, DHL announced the expansion of its dedicated pharmaceutical airfreight cold-chain network to provide temperature-controlled transportation for medicines, vaccines, pharmaceutical products, and cell and gene therapies. The company said the expanded network is designed to provide greater visibility and reliability for sensitive healthcare shipments.
02 Real-Time Visibility Improves Pharmaceutical Shipment Management Pharmaceutical companies and logistics providers are increasingly using digital tracking, temperature sensors, and centralized control towers to monitor shipments throughout their journey. Real-time information can help logistics teams identify temperature deviations, delays, and other issues before they affect product quality. This move toward connected supply chains is contributing to the increasing pharmaceutical logistics market size and improving shipment reliability. For instance, in August 2025, UPS Healthcare expanded its pharmaceutical logistics network with 20 advanced cross-dock facilities and enhanced real-time tracking through its UPS Healthcare Control Tower. The facilities were designed to improve the speed, reliability, and compliance of temperature-sensitive pharmaceutical shipments.
01 Growing Demand for Temperature-Controlled Pharmaceutical Distribution The market is being driven by the increasing need to move vaccines, biologics, specialty medicines, and other temperature-sensitive products safely from manufacturers to patients. These products require carefully controlled storage and transportation conditions, increasing demand for cold-chain warehouses, specialized packaging, monitoring systems, and validated transportation. WHO states that temperature mapping and monitoring are integral to maintaining appropriate pharmaceutical storage conditions.
01 High Cost of Cold-Chain Infrastructure and Specialized Handling The market faces pressure from the cost of maintaining refrigerated warehouses, temperature-controlled vehicles, monitoring equipment, specialized packaging, backup power, and trained personnel. Pharmaceutical logistics providers must also demonstrate that products remain within specified conditions throughout storage and transportation, adding to operational complexity. WHO guidance emphasizes systematic temperature mapping of cold rooms, freezers, refrigerators, and dry-storage areas to identify temperature variations that could affect pharmaceutical products.
01 Expansion of Biologics, Cell and Gene Therapies, and Advanced Cold Chains The market has strong opportunities as pharmaceutical pipelines increasingly include biologics, specialty medicines, vaccines, and cell and gene therapies requiring highly controlled logistics. These products create demand for specialized packaging, real-time monitoring, dedicated transportation, and end-to-end visibility, making advanced cold-chain capabilities an important pharmaceutical logistics market trend.
01 Maintaining Product Integrity During Long and Disrupted Supply Chains The market continues to face challenges from transportation delays, extreme temperatures, geopolitical disruptions, capacity shortages, and increasingly complex regulatory requirements. These risks can be particularly significant for high-value and temperature-sensitive medicines, where maintaining product integrity throughout the entire journey is essential.
March 2026 CEVA Logistics strengthened its healthcare logistics business through expanded temperature-controlled warehousing and transportation solutions for pharmaceutical manufacturers.
October 2025 Kuehne+Nagel expanded its pharmaceutical logistics network with additional certified healthcare distribution centers and enhanced cold chain transportation services.
July 2025 UPS Healthcare expanded its cold chain logistics capabilities through new temperature-controlled distribution facilities supporting biologics, vaccines, and specialty pharmaceuticals.
May 2025 DHL Group expanded its DHL Health Logistics network by opening new GDP-compliant pharmaceutical logistics facilities to strengthen temperature-controlled healthcare supply chains.